Search company, investor...

Targeted Growth

Founded Year



Convertible Note - II | Alive

Total Raised


Last Raised

$1.33M | 9 yrs ago

About Targeted Growth

Targeted Growth (TGI) is a crop & agricultural biotechnology company focused on developing products with enhanced yield and improved quality for the agriculture and energy industries.

Headquarters Location

2815 Eastlake Avenue East Suite 300

Seattle, Washington, 98102,

United States


Missing: Targeted Growth's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Targeted Growth's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Targeted Growth

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Targeted Growth is included in 2 Expert Collections, including Agriculture Technology (Agtech).


Agriculture Technology (Agtech)

1,905 items

Companies that are using technology to make farms more efficient.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Targeted Growth Patents

Targeted Growth has filed 1 patent.

The 3 most popular patent topics include:

  • Agriculture
  • Agronomy
  • Cell biology
patents chart

Application Date

Grant Date


Related Topics




Molecular biology, Genetics, Stylidium, Biotechnology, Gene expression


Application Date


Grant Date



Related Topics

Molecular biology, Genetics, Stylidium, Biotechnology, Gene expression



Latest Targeted Growth News

Analysis-China Central Bank To Offer Limited, Targeted Growth Support, No Bazooka

Dec 1, 2022

Paramilitary police officers stand guard in front of the headquarters of the People's Bank of China, the central bank (PBOC), in Beijing, China September 30, 2022. China's $17 trillion economy is headed for one of its worst showings this year in almost half a century, but its central bank has limited options in its armoury for providing policy support as it would want to avoid stoking capital flight. The People's Bank of China (PBOC) is, therefore, poised to ramp up targeted support for troubled sectors, adding to the nearly $800 billion in loans it has already made through its structural tools, according to policy sources and analysts. The PBOC, while seeking to bolster an economy hobbled by COVID-19 curbs and a property malaise, is expected to avoid aggressive stimulus that could fuel inflationary pressures and risk outflows from China, weakening the yuan, they said. The PBOC's room to maneuver has been crimped by a global tightening spree led by the U.S. Federal Reserve's aggressive rate rises to tame inflation, although Fed Chair Jerome Powell has hinted its pace will be slowed. Since 2020, when the world's second-largest economy was first jolted by the coronavirus, the PBOC has expanded its arsenal of structural policy tools, including relending and rediscount facilities and other low-cost loans. It has offered cheap loans to support small firms, transport and logistics - sectors hardest hit by COVID - and sectors that fit within Beijing's long-term development goals such as tech innovation, elderly care, and carbon reduction. "The central bank is likely to expand the scope of structural policy tools and step up the use of such tools," said a person involved in policy discussions who spoke on condition of anonymity. "We will not resort to flood-like stimulus, but will make policy more targeted and more efficient to ensure reasonable and sufficient liquidity." The PBOC did not respond to Reuters' request for comment. Its outstanding loans made via structural tools amounted to nearly 5.6 trillion yuan ($781.64 billion) at the end of September, central bank data showed. The PBOC has pledged 200 billion yuan in special loans last month to rescue the property sector, and 154.3 billion yuan in loans in October to policy banks via its pledged supplementary Lending (PSL) facility to fund infrastructure projects. The central bank last week announced it would cut banks' reserve requirement ratio (RRR) for the second time this year, releasing about 500 billion yuan in long-term liquidity, reducing the room for using the traditional tool. The average reserve ratio has been slashed to 7.8% from 14.9% in 2018. "What I expect is that the PBOC will exercise some form of unconventional monetary policy to increase the efficiency of this RRR cut," Iris Pang, chief economist for Greater China at ING, said in a note. To channel more credit into targeted sectors, the central bank could raise its re-lending quota for small firms, boost lending for unfinished residential projects, and guide commercial banks to speed up loan growth, Pang said. POLICY CONSTRAINTS All eyes are on the closed-door Central Economic Work Conference in December, when Chinese leaders are expected to chart the policy course for the economy in 2023. Chinese government advisers have told Reuters that they would recommend economic growth targets for 2023 ranging from 4.5% to 5.5%. A central bank adviser said last month that China should set a growth target no lower than 5% for next year. Top leaders are expected to endorse a target at the December meeting, although it will not be announced publicly until China's annual parliament meeting, usually held in March. Beijing is likely to double down on an infrastructure push in 2023, issuing more debt to fund big-ticket projects, while the PBOC supports with modest easing, policy sources said. "We face some policy constraints (from the Fed moves), there is no doubt about that," Yu Yongding, an influential government economist who previously advised the central bank, told Reuters. "But there is room for monetary policy easing as long as inflation does not pick up. The main danger for China's economy is that the growth rate is too slow." China is on track to miss the official growth target of "around" 5.5% this year, with economists forecasting it to grow by about 3%. Excluding the 2.2% expansion in 2020, it would be the weakest growth since 1976, the final year of the decade-long Cultural Revolution that wrecked the economy. Analysts see no imminent inflation pressure, but the PBOC has warned that inflation could pick up once consumption recovers. Consumer inflation eased to 2.1% in October. On Nov. 21, the central bank kept its benchmark lending rates unchanged for a third straight month. The one-year loan prime rate (LPR) was kept at 3.65%. The yuan has fallen about 10% against the U.S. dollar this year, despite China's capital controls. ($1 = 7.1644 Chinese yuan renminbi) © Copyright Thomson Reuters 2022. All rights reserved. FOLLOW MORE IBT NEWS ON THE BELOW CHANNELS IBT Fast Start - Let the best of International News come to you Sign up and stay up to date with our daily newsletter. You can unsubscribe at any time. By signing up you are agreeing to our Terms of Service and Privacy Policy . MOST READ IN Economy

Targeted Growth Frequently Asked Questions (FAQ)

  • When was Targeted Growth founded?

    Targeted Growth was founded in 1998.

  • Where is Targeted Growth's headquarters?

    Targeted Growth's headquarters is located at 2815 Eastlake Avenue East, Seattle.

  • What is Targeted Growth's latest funding round?

    Targeted Growth's latest funding round is Convertible Note - II.

  • How much did Targeted Growth raise?

    Targeted Growth raised a total of $45.33M.

  • Who are the investors of Targeted Growth?

    Investors of Targeted Growth include GrowthWorks, Capricorn Investment Group, Barkley Ag Enterprises, AllianceBernstein, WRF Capital and 6 more.

  • Who are Targeted Growth's competitors?

    Competitors of Targeted Growth include Cathay Industrial Biotech, Agrivida, PDS Biotechnology, Chromatin, ReInnervate and 11 more.

Compare Targeted Growth to Competitors

Stine Seed Logo
Stine Seed

Stine Seed is an independent seed company dedicated to serving farmer customers with support from its team of agronomists and district and regional managers.

Integrated Plant Genetics

Integrated Plant Genetics, Inc. is a development stage biotechnology company, in business to produce and license genes and technologies for the purposes of microbial, horticultural, agricultural and forest tree improvement, including pathogen control. IPG aims to provide contract genetic engineering services, advanced plant breeding technologies for freedom to operate in creating transgenic crops, and assistance in developing regulatory data submission packages. IPG offers environmentally sound and sustainable alternatives to costly and often toxic chemical pest control methods. IPG is a Florida-grown company, with strong ties to the University of Florida, and a commitment to Florida agriculture.

SweTree Technologies

SweTree Technologies is a plant and forest biotechnology company providing products and technologies to improve the productivity and performance properties of seedlings, wood and fiber for forestry, pulp & paper, packaging, hygiene, textile and other fiber related industries.

SemBioSys Genetics

SemBioSys Genetics Inc is a biotechnology company focused on the development commercialization and production of protein-based pharmaceuticals and nonpharmaceutical products based on our plant genetic engineering skills and our proprietary oilbodyoleosin technology platform, the Stratosome Biologic System

Agrisoma BioSciences

Agrisoma Biosciences is an agricultural company that has commercialized carinata, a non-food oilseed crop designed for sustainable production of biofuels. Agrisoma sells carinata seed products under the Resonance brand name, and uses advanced crop improvement technologies to provide superior crop varieties to growers.

Chef Solutions

Chef Solutions is a corporate entity consisting of the Orval Kent Foods Co. Orval Kent is a provider of prepared foods and meal solutions to the retail and food service industries.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.